FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40104111000001108: Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2041741000001115 Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2041751000001117 Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has AMP Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Is a Generic Ryeqo 40mg/1mg/0.5mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has specific active ingredient Estradiol hemihydrate true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has specific active ingredient Relugolix false Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Estradiol true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has specific active ingredient Norethisterone acetate true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Ryeqo 40mg/1mg/0.5mg tablets (Gedeon Richter (UK) Ltd) 28 tablet Has specific active ingredient Relugolix true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start